Cargando…
Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis
BACKGROUND: Chronic atrophic gastritis (CAG) is defined as an important precancerous disease with high risk of gastric cancer. Rebamipide is a mucosal protective agent widely used in the treatment of chronic gastritis. The aim of this systematic review is to assess the efficacy and safety of rebamip...
Autores principales: | Hou, Daorui, Yang, Maoyi, Hu, Zhipeng, Yang, Liangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310858/ https://www.ncbi.nlm.nih.gov/pubmed/32569191 http://dx.doi.org/10.1097/MD.0000000000020620 |
Ejemplares similares
-
A comprehensive evaluation of single nucleotide polymorphisms associated with atrophic gastritis risk: A protocol for systematic review and network meta-analysis
por: Tang, Zhen-Yu, et al.
Publicado: (2020) -
The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis
por: Wang, Xu, et al.
Publicado: (2016) -
Effects of folic acid supplementation on chronic atrophic gastritis based on MTHFR C677T polymorphism
por: Kong, Siya, et al.
Publicado: (2023) -
An Observational Study on Aberrant Methylation of Runx3 With the Prognosis in Chronic Atrophic Gastritis Patients
por: Zhao, Chunna, et al.
Publicado: (2016) -
Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies
por: Liu, Hong, et al.
Publicado: (2017)